Latham & Watkins Advises NEA on Acquisition and Take Private of NeueHealth With Consortium of Investors

NeueHealth, Inc. (NeueHealth or the Company) (NYSE: NEUE), the value-driven healthcare company, has announced that it has entered into a definitive merger agreement pursuant to which the Company will be acquired by an affiliate of New Enterprise Associates (NEA) at an enterprise value of approximately US$1.3 billion. Upon completion of the transaction, NeueHealth will become a privately held company with the flexibility and resources to continue advancing its value-driven, consumer-centric care model.

Latham & Watkins LLP represents NEA in the transaction with a corporate deal team led by Chicago partners Daniel Breslin and Max Schleusener, with associates Grace Kim, Diana DuBois, and Amarantha Gomez. Advice was also provided on financing matters by New York partners Peter Sluka and Andrew Blumenthal, Chicago partner Cindy Caillavet, and Chicago counsel Katherine Stork, with associate Claire Solimine; on tax matters by Chicago partner Diana Doyle, with associates Michael Zucker and Valerie Silva Parra; on employee benefits matters by Chicago partner Benjamin Rosemergy, with associate Ellie Graham; on securities regulatory matters by Washington, D.C. partner Brian Miller, with associate Kaj Nielsen; and on healthcare regulatory matters by Washington, D.C. partner Jason Caron, with associate Chad Leiper.